• SENSEX
    NIFTY 50
Market

Aurobindo Pharma shares tumble 9% after USFDA issues Form 483 for Hyderabad facility

Updated : November 14, 2019 10:13 AM IST

Shares of Aurobindo Pharma tumbled over 9 percent on Thursday after the US drug regulator issued a 'Form 483' to its Hyderabad facility with 14 observations.
The pharma company said that they believe that none of these observations are related to data integrity issues.
Earlier this week, the company also reported its September-quarter numbers.
Aurobindo Pharma shares tumble 9% after USFDA issues Form 483 for Hyderabad facility
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more

You May Also Like

Live TV